GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $225,000 | +114.3% | 2,527 | -23.4% | 0.00% | – |
| Q2 2022 | $105,000 | -7.9% | 3,298 | 0.0% | 0.00% | – |
| Q1 2022 | $114,000 | +17.5% | 3,298 | 0.0% | 0.00% | – |
| Q4 2021 | $97,000 | +11.5% | 3,298 | -3.3% | 0.00% | – |
| Q3 2021 | $87,000 | +70.6% | 3,411 | +133.3% | 0.00% | – |
| Q2 2021 | $51,000 | -25.0% | 1,462 | -12.1% | 0.00% | – |
| Q1 2021 | $68,000 | -27.7% | 1,663 | -23.6% | 0.00% | – |
| Q4 2020 | $94,000 | -93.8% | 2,178 | -92.1% | 0.00% | -100.0% |
| Q3 2020 | $1,518,000 | -9.1% | 27,531 | +4.1% | 0.00% | 0.0% |
| Q2 2020 | $1,670,000 | +37.8% | 26,456 | +11.5% | 0.00% | +50.0% |
| Q1 2020 | $1,212,000 | +854.3% | 23,725 | +1382.8% | 0.00% | – |
| Q4 2019 | $127,000 | -89.8% | 1,600 | -93.8% | 0.00% | -100.0% |
| Q1 2018 | $1,243,000 | +10258.3% | 25,737 | +8479.0% | 0.00% | – |
| Q4 2017 | $12,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |